Furthermore, HFD-induced dyslipidemia contributes to leptin resistance and adiposity; however, the combination of PUFAs and vitamin K2 in GmOLb likely exerts synergistic effects by enhancing lipid metabolism, reducing inflammation, and supporting energy homeostasis. Here, LEP is linked to metabolic syndrome.